| - GRCh37:
- Chr18:29172878
- GRCh38:
- Chr18:31592915
| TTR | C30Y | Amyloidogenic transthyretin amyloidosis | Likely pathogenic (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172883
- GRCh38:
- Chr18:31592920
| TTR | L32V | Cardiovascular phenotype, Amyloidogenic transthyretin amyloidosis | Pathogenic (Feb 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29172884
- GRCh38:
- Chr18:31592921
| TTR | L32P | not specified | Pathogenic (Jun 5, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172901
- GRCh38:
- Chr18:31592938
| TTR | D38N | Amyloidogenic transthyretin amyloidosis, Cardiovascular phenotype | Pathogenic (Sep 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29172902
- GRCh38:
- Chr18:31592939
| TTR | D38G | Amyloidogenic transthyretin amyloidosis | Pathogenic (Jul 13, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29172903
- GRCh38:
- Chr18:31592940
| TTR | D38E | Amyloidogenic transthyretin amyloidosis | Pathogenic (Nov 5, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172905
- GRCh38:
- Chr18:31592942
| TTR | A39D | Cardiovascular phenotype, Amyloidogenic transthyretin amyloidosis | Pathogenic/Likely pathogenic (Jul 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29172907
- GRCh38:
- Chr18:31592944
| TTR | V40I | Cardiovascular phenotype, not provided, Amyloidogenic transthyretin amyloidosis
| Pathogenic (Oct 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29172908
- GRCh38:
- Chr18:31592945
| TTR | V40A | Amyloidogenic transthyretin amyloidosis | Likely pathogenic (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172917
- GRCh38:
- Chr18:31592954
| TTR | S43N | Cardiovascular phenotype, Amyloidogenic transthyretin amyloidosis, not provided
| Pathogenic/Likely pathogenic (Oct 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29172919
- GRCh38:
- Chr18:31592956
| TTR | P44S | not provided, Amyloidogenic transthyretin amyloidosis, Cardiovascular phenotype
| Pathogenic (Jul 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29172920
- GRCh38:
- Chr18:31592957
| TTR | P44L | Amyloidogenic transthyretin amyloidosis | Likely pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172922
- GRCh38:
- Chr18:31592959
| TTR | A45S | Cardiovascular phenotype | Likely pathogenic (Dec 5, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172922
- GRCh38:
- Chr18:31592959
| TTR | A45T | AMYLOIDOSIS, LEPTOMENINGEAL, TRANSTHYRETIN-RELATED, Amyloidogenic transthyretin amyloidosis | Pathogenic (Apr 14, 2009) | no assertion criteria provided |
| - GRCh37:
- Chr18:29172937
- GRCh38:
- Chr18:31592974
| TTR | V50L | Amyloidogenic transthyretin amyloidosis | Pathogenic (Jul 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172937
- GRCh38:
- Chr18:31592974
| TTR | V50L | Cardiovascular phenotype, Charcot-Marie-Tooth disease, Amyloidogenic transthyretin amyloidosis
| Pathogenic (Sep 5, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29172937
- GRCh38:
- Chr18:31592974
| TTR | V50M | Amyloidogenic transthyretin amyloidosis, Hyperthyroxinemia, dystransthyretinemic, Carpal tunnel syndrome 1, Cardiovascular phenotype, Charcot-Marie-Tooth disease, not provided, Cardiomyopathy, Amyloidogenic transthyretin amyloidosis | Pathogenic (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29172938
- GRCh38:
- Chr18:31592975
| TTR | V50G | Amyloidogenic transthyretin amyloidosis | Pathogenic (Sep 21, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172938
- GRCh38:
- Chr18:31592975
| TTR | V50A | Amyloidogenic transthyretin amyloidosis | Pathogenic (Sep 18, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29172944
- GRCh38:
- Chr18:31592981
| TTR | V52A | Amyloidogenic transthyretin amyloidosis, Cardiovascular phenotype | Likely pathogenic (Sep 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29172946
- GRCh38:
- Chr18:31592983
| TTR | F53L | Cardiovascular phenotype, not provided, Amyloidogenic transthyretin amyloidosis
| Pathogenic/Likely pathogenic (Jan 9, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29172946
- GRCh38:
- Chr18:31592983
| TTR | F53I | Amyloidogenic transthyretin amyloidosis | Pathogenic (Feb 1, 1993) | no assertion criteria provided |
| - GRCh37:
- Chr18:29172949
- GRCh38:
- Chr18:31592986
| TTR | R54G | Amyloidogenic transthyretin amyloidosis | Pathogenic (Aug 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172950
- GRCh38:
- Chr18:31592987
| TTR | R54T | Amyloidogenic transthyretin amyloidosis | Pathogenic (Oct 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172952
- GRCh38:
- Chr18:31592989
| TTR | K55E | Amyloidogenic transthyretin amyloidosis | Likely pathogenic (Dec 21, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172954
- GRCh38:
- Chr18:31592991
| TTR | K55N | Amyloidogenic transthyretin amyloidosis | Pathogenic (Sep 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172954
- GRCh38:
- Chr18:31592991
| TTR | K55N | not provided, Amyloidogenic transthyretin amyloidosis | Likely pathogenic (Jul 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29172955
- GRCh38:
- Chr18:31592992
| TTR | A56P | Amyloidogenic transthyretin amyloidosis | Pathogenic (Jun 14, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr18:29172961
- GRCh38:
- Chr18:31592998
| TTR | D58H | Amyloidogenic transthyretin amyloidosis, Cardiovascular phenotype | Pathogenic/Likely pathogenic (Aug 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29172962
- GRCh38:
- Chr18:31592999
| TTR | D58V | Amyloidogenic transthyretin amyloidosis | Pathogenic (Mar 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172962
- GRCh38:
- Chr18:31592999
| TTR | D58A | Cardiovascular phenotype, not provided, Amyloidogenic transthyretin amyloidosis
| Pathogenic (Sep 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29172968
- GRCh38:
- Chr18:31593005
| TTR | T60N | Amyloidogenic transthyretin amyloidosis, Cardiovascular phenotype | Likely pathogenic (Jan 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29172971
- GRCh38:
- Chr18:31593008
| TTR | W61L | Amyloidogenic transthyretin amyloidosis | Pathogenic (Sep 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172974
- GRCh38:
- Chr18:31593011
| TTR | E62G | Amyloidogenic transthyretin amyloidosis | Pathogenic (Aug 1, 1992) | no assertion criteria provided |
| - GRCh37:
- Chr18:29172975
- GRCh38:
- Chr18:31593012
| TTR | E62D | Amyloidogenic transthyretin amyloidosis | Likely pathogenic (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172980
- GRCh38:
- Chr18:31593017
| TTR | F64S | Cardiovascular phenotype, Amyloidogenic transthyretin amyloidosis | Pathogenic/Likely pathogenic (Jul 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29172982
- GRCh38:
- Chr18:31593019
| TTR | A65T | not provided, Cardiovascular phenotype, Amyloidogenic transthyretin amyloidosis
| Pathogenic/Likely pathogenic (Aug 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29172983
- GRCh38:
- Chr18:31593020
| TTR | A65D | Amyloidogenic transthyretin amyloidosis, not provided | Pathogenic/Likely pathogenic (Sep 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29172988
- GRCh38:
- Chr18:31593025
| TTR | | Amyloidogenic transthyretin amyloidosis | Pathogenic (Apr 1, 2000) | no assertion criteria provided |
| - GRCh37:
- Chr18:29172988
- GRCh38:
- Chr18:31593025
| TTR | | Amyloidogenic transthyretin amyloidosis | Pathogenic (Apr 1, 2000) | no assertion criteria provided |
| - GRCh37:
- Chr18:29172989
- GRCh38:
- Chr18:31593026
| TTR | G67V | Amyloidogenic transthyretin amyloidosis, Cardiovascular phenotype | Pathogenic/Likely pathogenic (Aug 30, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29172989
- GRCh38:
- Chr18:31593026
| TTR | G67E | Cardiovascular phenotype, Amyloidogenic transthyretin amyloidosis | Pathogenic (Sep 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29172989
- GRCh38:
- Chr18:31593026
| TTR | G67A | Cardiovascular phenotype, not provided, Amyloidogenic transthyretin amyloidosis
| Pathogenic (Dec 29, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29175087
- GRCh38:
- Chr18:31595124
| TTR | T69A | Amyloidogenic transthyretin amyloidosis | Pathogenic (Feb 13, 1997) | no assertion criteria provided |
| - GRCh37:
- Chr18:29175088
- GRCh38:
- Chr18:31595125
| TTR | T69I | Amyloidogenic transthyretin amyloidosis | Pathogenic (Aug 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175088
- GRCh38:
- Chr18:31595125
| TTR | T69S | Amyloidogenic transthyretin amyloidosis | Pathogenic (Aug 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175090
- GRCh38:
- Chr18:31595127
| TTR | S70G | Amyloidogenic transthyretin amyloidosis | Likely pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175090
- GRCh38:
- Chr18:31595127
| TTR | S70R | Amyloidogenic transthyretin amyloidosis | Likely pathogenic (Aug 18, 2011) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175091-29175092
- GRCh38:
- Chr18:31595128-31595129
| TTR | | Amyloidogenic transthyretin amyloidosis | Pathogenic (Mar 16, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr18:29175091
- GRCh38:
- Chr18:31595128
| TTR | S70I | Amyloidogenic transthyretin amyloidosis | Pathogenic (Aug 31, 1992) | no assertion criteria provided |
| - GRCh37:
- Chr18:29175092
- GRCh38:
- Chr18:31595129
| TTR | S70R | not provided, Amyloidogenic transthyretin amyloidosis, Cardiovascular phenotype
| Pathogenic (Oct 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29175092
- GRCh38:
- Chr18:31595129
| TTR | S70R | Cardiovascular phenotype, Amyloidogenic transthyretin amyloidosis | Pathogenic (Jul 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29175096
- GRCh38:
- Chr18:31595133
| TTR | S72P | Amyloidogenic transthyretin amyloidosis, Cardiovascular phenotype | Pathogenic (Aug 17, 2017) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29175099
- GRCh38:
- Chr18:31595136
| TTR | G73R | Amyloidogenic transthyretin amyloidosis | Likely pathogenic (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175100
- GRCh38:
- Chr18:31595137
| TTR | G73E | AMYLOIDOSIS, LEPTOMENINGEAL, TRANSTHYRETIN-RELATED | Pathogenic (Jul 10, 2001) | no assertion criteria provided |
| - GRCh37:
- Chr18:29175102-29175103
- GRCh38:
- Chr18:31595139-31595140
| TTR | E74L | Amyloidogenic transthyretin amyloidosis, Cardiovascular phenotype | Pathogenic/Likely pathogenic (Oct 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29175102
- GRCh38:
- Chr18:31595139
| TTR | E74K | Cardiovascular phenotype, not provided, Amyloidogenic transthyretin amyloidosis
| Pathogenic (May 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29175103
- GRCh38:
- Chr18:31595140
| TTR | E74A | Amyloidogenic transthyretin amyloidosis | Likely pathogenic (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175103
- GRCh38:
- Chr18:31595140
| TTR | E74G | not specified, Cardiovascular phenotype, not provided
| Pathogenic/Likely pathogenic (Jun 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29175105
- GRCh38:
- Chr18:31595142
| TTR | L75M | Amyloidogenic transthyretin amyloidosis | Pathogenic (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175106
- GRCh38:
- Chr18:31595143
| TTR | L75R | Amyloidogenic transthyretin amyloidosis | Pathogenic (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175106
- GRCh38:
- Chr18:31595143
| TTR | L75P | Amyloidogenic transthyretin amyloidosis | Pathogenic (Jan 1, 1997) | no assertion criteria provided |
| - GRCh37:
- Chr18:29175111
- GRCh38:
- Chr18:31595148
| TTR | G77R | Amyloidogenic transthyretin amyloidosis | Pathogenic (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175115
- GRCh38:
- Chr18:31595152
| TTR | L78R | Amyloidogenic transthyretin amyloidosis | Pathogenic (Oct 15, 1991) | no assertion criteria provided |
| - GRCh37:
- Chr18:29175115
- GRCh38:
- Chr18:31595152
| TTR | L78H | Cardiovascular phenotype, not provided, Amyloidogenic transthyretin amyloidosis
| Pathogenic/Likely pathogenic (Oct 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29175117
- GRCh38:
- Chr18:31595154
| TTR | T79A | Amyloidogenic transthyretin amyloidosis | Likely pathogenic (Apr 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175118
- GRCh38:
- Chr18:31595155
| TTR | T79K | not provided | Likely pathogenic (May 11, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175120
- GRCh38:
- Chr18:31595157
| TTR | T80A | Cardiovascular phenotype, Charcot-Marie-Tooth disease, Cardiomyopathy, not provided, Amyloidogenic transthyretin amyloidosis | Pathogenic/Likely pathogenic (Nov 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29175121
- GRCh38:
- Chr18:31595158
| TTR | T80I | Amyloidogenic transthyretin amyloidosis, not provided, Cardiovascular phenotype
| Pathogenic/Likely pathogenic (Jun 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29175123
- GRCh38:
- Chr18:31595160
| TTR | E81K | Cardiovascular phenotype | Likely pathogenic (Jan 30, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175124
- GRCh38:
- Chr18:31595161
| TTR | E81A | Cardiovascular phenotype | Likely pathogenic (Mar 10, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175126
- GRCh38:
- Chr18:31595163
| TTR | E82K | Cardiovascular phenotype, Amyloidogenic transthyretin amyloidosis | Pathogenic/Likely pathogenic (Nov 29, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29175132
- GRCh38:
- Chr18:31595169
| TTR | F84L | Cardiovascular phenotype, not provided, Amyloidogenic transthyretin amyloidosis, Carpal tunnel syndrome, Hyperthyroxinemia, dystransthyretinemic, Amyloidogenic transthyretin amyloidosis
| Pathogenic (Jan 9, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29175133
- GRCh38:
- Chr18:31595170
| TTR | F84Y | Amyloidogenic transthyretin amyloidosis | Likely pathogenic (Jul 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175133
- GRCh38:
- Chr18:31595170
| TTR | F84S | Amyloidogenic transthyretin amyloidosis | Likely pathogenic (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175134
- GRCh38:
- Chr18:31595171
| TTR | F84L | Charcot-Marie-Tooth disease, Amyloidogenic transthyretin amyloidosis | Pathogenic/Likely pathogenic (Mar 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29175140
- GRCh38:
- Chr18:31595177
| TTR | E86D | Amyloidogenic transthyretin amyloidosis | Likely pathogenic (Sep 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175141
- GRCh38:
- Chr18:31595178
| TTR | G87R | Amyloidogenic transthyretin amyloidosis | Likely pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175144
- GRCh38:
- Chr18:31595181
| TTR | I88L | Amyloidogenic transthyretin amyloidosis, Hyperthyroxinemia, dystransthyretinemic, Carpal tunnel syndrome 1, Cardiovascular phenotype, not provided, Amyloidogenic transthyretin amyloidosis
| Pathogenic/Likely pathogenic (Jan 9, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29175147
- GRCh38:
- Chr18:31595184
| TTR | Y89H | Cardiovascular phenotype, not provided, Amyloidogenic transthyretin amyloidosis
| Pathogenic/Likely pathogenic (Jan 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29175150
- GRCh38:
- Chr18:31595187
| TTR | K90Q | Amyloidogenic transthyretin amyloidosis | Likely pathogenic (Apr 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175152
- GRCh38:
- Chr18:31595189
| TTR | K90N | Amyloidogenic transthyretin amyloidosis | Pathogenic (Nov 1, 1992) | no assertion criteria provided |
| - GRCh37:
- Chr18:29175154
- GRCh38:
- Chr18:31595191
| TTR | V91A | Amyloidogenic transthyretin amyloidosis | Pathogenic (Feb 13, 1997) | no assertion criteria provided |
| - GRCh37:
- Chr18:29175159
- GRCh38:
- Chr18:31595196
| TTR | I93V | Amyloidogenic transthyretin amyloidosis, Hereditary amyloidosis | Pathogenic/Likely pathogenic (Aug 27, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29175172
- GRCh38:
- Chr18:31595209
| TTR | S97F | Cardiovascular phenotype | Pathogenic (Apr 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175172
- GRCh38:
- Chr18:31595209
| TTR | S97Y | Cardiovascular phenotype, Amyloidogenic transthyretin amyloidosis, Hyperthyroxinemia, dystransthyretinemic, Carpal tunnel syndrome 1, Charcot-Marie-Tooth disease, not specified, not provided, Amyloidogenic transthyretin amyloidosis | Pathogenic/Likely pathogenic (Aug 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29175175
- GRCh38:
- Chr18:31595212
| TTR | Y98F | Cardiovascular phenotype, Amyloidogenic transthyretin amyloidosis | Pathogenic/Likely pathogenic (Sep 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29175193
- GRCh38:
- Chr18:31595230
| TTR | I104T | Amyloidogenic transthyretin amyloidosis, Cardiovascular phenotype | Pathogenic/Likely pathogenic (Aug 26, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29175193
- GRCh38:
- Chr18:31595230
| TTR | I104S | Cardiovascular phenotype, not provided, Amyloidogenic transthyretin amyloidosis
| Pathogenic (Aug 12, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29175205
- GRCh38:
- Chr18:31595242
| TTR | H108R | Cardiovascular phenotype, Amyloidogenic transthyretin amyloidosis | Pathogenic (Aug 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29175207
- GRCh38:
- Chr18:31595244
| TTR | E109K | not provided, Amyloidogenic transthyretin amyloidosis, Cardiovascular phenotype
| Pathogenic/Likely pathogenic (Sep 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29175207
- GRCh38:
- Chr18:31595244
| TTR | E109Q | Cardiovascular phenotype, not provided, Amyloidogenic transthyretin amyloidosis
| Pathogenic (Sep 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29178543
- GRCh38:
- Chr18:31598580
| TTR | A117S | Cardiovascular phenotype, Carpal tunnel syndrome 1, Hyperthyroxinemia, dystransthyretinemic, Amyloidogenic transthyretin amyloidosis, not provided, Amyloidogenic transthyretin amyloidosis
| Pathogenic/Likely pathogenic (Sep 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29178544
- GRCh38:
- Chr18:31598581
| TTR | A117D | Amyloidogenic transthyretin amyloidosis | Likely pathogenic (Dec 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29178544
- GRCh38:
- Chr18:31598581
| TTR | A117G | Amyloidogenic transthyretin amyloidosis | Pathogenic (Jan 1, 1994) | no assertion criteria provided |
| - GRCh37:
- Chr18:29178571
- GRCh38:
- Chr18:31598608
| TTR | T126N | Amyloidogenic transthyretin amyloidosis | Likely pathogenic (Mar 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29178573
- GRCh38:
- Chr18:31598610
| TTR | I127V | Hyperthyroxinemia, dystransthyretinemic, Carpal tunnel syndrome 1, Amyloidogenic transthyretin amyloidosis, Cardiovascular phenotype, not specified, not provided, Amyloidogenic transthyretin amyloidosis | Pathogenic/Likely pathogenic (Oct 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29178575
- GRCh38:
- Chr18:31598612
| TTR | I127M | Amyloidogenic transthyretin amyloidosis, Cardiovascular phenotype | Pathogenic/Likely pathogenic (Jul 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29178585
- GRCh38:
- Chr18:31598622
| TTR | L131M | Amyloidogenic transthyretin amyloidosis | Pathogenic (Oct 1, 1993) | no assertion criteria provided |
| - GRCh37:
- Chr18:29178594
- GRCh38:
- Chr18:31598631
| TTR | Y134H | Carpal tunnel syndrome 1 | Pathogenic (Feb 1, 1994) | no assertion criteria provided |